Curis
CRIS
#10357
Rank
S$23.91 M
Marketcap
S$0.61
Share price
0.68%
Change (1 day)
-80.56%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): S-$4.87

According to Curis's latest financial reports the company's current EPS (TTM) is S-$4.73. In 2024 the company made an earnings per share (EPS) of S-$9.05 an increase over its 2023 EPS that were of S-$11.63.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$4.87-46.15%
2024S-$9.05-22.15%
2023S-$11.63-26.17%
2022S-$15.7522.3%
2021S-$12.88-25.37%
2020S-$17.25-30.93%
2019S-$24.98-2.02%
2018S-$25.50
2016S-$57.94-10%
2015S-$64.38138.1%
2014S-$27.0440%
2013S-$19.31-25%
2012S-$25.7566.67%
2011S-$15.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.69-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$4.58-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$4.03-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.01 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$14.47 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.82-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA